PTX.AX - Prescient Therapeutics Limited
ASX - ASX Delayed price. Currency in AUD
0.0510
+0.0030 (+6.25%)
At close: 3:58PM AEST
Stock chart is not supported by your current browser
| Previous close | 0.0480 |
| Open | 0.0480 |
| Bid | 0.0500 x 0 |
| Ask | 0.0510 x 0 |
| Day's range | 0.0480 - 0.0510 |
| 52-week range | 0.0220 - 0.1500 |
| Volume | 1,262,284 |
| Avg. volume | 2,082,548 |
| Market cap | 20.107M |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0120 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Prescient Therapeutics Limited's (ASX:PTX) CEO Being Overpaid?
In 2016, Yatomi-Clarke Lee was appointed CEO of Prescient Therapeutics Limited (ASX:PTX). First, this article will...
- Simply Wall St.
The Prescient Therapeutics (ASX:PTX) Share Price Is Down 63% So Some Shareholders Are Wishing They Sold
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big...
- Simply Wall St.
Read This Before Selling Prescient Therapeutics Limited (ASX:PTX) Shares
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
- Simply Wall St.
What Kind Of Investor Owns Most Of Prescient Therapeutics Limited (ASX:PTX)?
Every investor in Prescient Therapeutics Limited (ASX:PTX) should be aware of the most powerful shareholder groups...
- Simply Wall St.
Is Prescient Therapeutics Limited (ASX:PTX) Excessively Paying Its CEO?
In 2016 Yatomi-Clarke Lee was appointed CEO of Prescient Therapeutics Limited (ASX:PTX). This analysis aims first to...
- Simply Wall St.
How Much Are Prescient Therapeutics Limited (ASX:PTX) Insiders Spending On Buying Shares?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
